The objective of the FLOW trial was to see if Ozempic delayed CKD progression and lowered risk of kidney- and cardiovascular-related death
These effects lead to hippocampus-dependent cognitive loss, including difficulties with spatial learning and memory, as well as neurodegeneration, inflammation, and synaptic malfunction
Individuals with high-responder genetic profiles may achieve target results weeks faster than the general population timeline
The key difference may be in the magnitude of caloric deficit
Pisa LW, Amaral-Rogers V, Belzunces LP, Bonmatin JM, Downs CA, Goulson D, Kreutzweiser DP, Krupke C, Liess M, Mcfield M, Morrissey CA, Noome DA, Settele J, Simon-Delso N, Stark JD, Van Der Sluijs JP, Van Dyck H, Wiemers M (2014) Effects of neonicotinoids and fipronil on non-target invertebrates
This is what TRT therapy really looks like